Healthcare provider profile · identity verified

Mir Akbar Khan, MD

Allopathic & Osteopathic Physicians|Internal Medicine · LAKE CHARLES, LA · NPI 1669448080

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Mir Akbar Khan, MD received $104.32 in general payments during 2025 across 6 reported records.

ABBVIE INC. accounted for 36.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported HUMIRA as an associated drug or biological on 1828 records involving 689 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Humira by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 127 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Vraylar by this doctor in 2024.

Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$104.32

6 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$37.90	36.3%	2	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$18.31	17.6%	1	2025
Currax Pharmaceuticals LLC	Unresolved — no canonical attribution shown	$17.17	16.5%	1	2025
Lundbeck LLC	Unresolved — no canonical attribution shown	$17.02	16.3%	1	2025
Solventum Corporation	Unresolved — no canonical attribution shown	$13.92	13.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$104.32	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$37.90	2	2025
Source payment records 2025-03-28 · ABBVIE INC. · $15.29 · Open Payments source 2025-11-04 · ABBVIE INC. · $22.61 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$22.61	1	2025
Source payment records 2025-11-04 · ABBVIE INC. · $22.61 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.31	1	2025
Source payment records 2025-07-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $18.31 · Open Payments source
CONTRAVE Normalized: contrave	Drug	Currax Pharmaceuticals LLC	$17.17	1	2025
Source payment records 2025-05-19 · Currax Pharmaceuticals LLC · $17.17 · Open Payments source
REXULTI Normalized: rexulti	Drug	Lundbeck LLC	$17.02	1	2025
Source payment records 2025-10-07 · Lundbeck LLC · $17.02 · Open Payments source
ACTIV.A.C. Normalized: activ a c	Device	Solventum Corporation	$13.92	1	2025
Source payment records 2025-05-06 · Solventum Corporation · $13.92 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	13 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	HUMIRA open payments reported associated product	CMS Open Payments — General Payments 1828 supporting records · 689 recipient NPIs · example record 1201353784	Humira · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	127	17
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	28	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
Lundbeck LLC Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986	Rexulti · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	828	123
Pantoprazole Sodium	Pantoprazole Sodium	707	125
Atorvastatin Calcium	Atorvastatin Calcium	646	106
Eliquis	Apixaban	473	43
Gabapentin	Gabapentin	473	79
Amlodipine Besylate	Amlodipine Besylate	441	88
Sertraline Hcl	Sertraline Hcl	408	53
Furosemide	Furosemide	362	68
Alprazolam	Alprazolam	359	59
Metoprolol Tartrate	Metoprolol Tartrate	347	63
Tamsulosin Hcl	Tamsulosin Hcl	335	49
Potassium Chloride	Potassium Chloride	297	60
Trazodone Hcl	Trazodone Hcl	293	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	280	59
Lisinopril	Lisinopril	267	50
Losartan Potassium	Losartan Potassium	267	49
Januvia	Sitagliptin Phosphate	260	20
Risperidone	Risperidone	251	28
Clonazepam	Clonazepam	221	31
Donepezil Hcl	Donepezil Hcl	220	35
Escitalopram Oxalate	Escitalopram Oxalate	220	37
Memantine Hcl	Memantine Hcl	204	29
Hydralazine Hcl	Hydralazine Hcl	203	42
Buspirone Hcl	Buspirone Hcl	195	33
Mirtazapine	Mirtazapine	194	29
Levetiracetam	Levetiracetam	192	26
Carvedilol	Carvedilol	189	40
Clopidogrel	Clopidogrel Bisulfate	188	37
Rosuvastatin Calcium	Rosuvastatin Calcium	187	33
Pravastatin Sodium	Pravastatin Sodium	182	35
Divalproex Sodium	Divalproex Sodium	178	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	170	29
Metformin Hcl	Metformin Hcl	164	33
Montelukast Sodium	Montelukast Sodium	162	33
Famotidine	Famotidine	160	23
Finasteride	Finasteride	156	29
Lantus	Insulin Glargine,hum.Rec.Anlog	152	19
Quetiapine Fumarate	Quetiapine Fumarate	151	24
Metoprolol Succinate	Metoprolol Succinate	150	29
Olanzapine	Olanzapine	148	13
Duloxetine Hcl	Duloxetine Hcl	147	22
Quetiapine Fumarate Er	Quetiapine Fumarate	138	13
Hydrochlorothiazide	Hydrochlorothiazide	133	24
Midodrine Hcl	Midodrine Hcl	133	24
Liothyronine Sodium	Liothyronine Sodium	132	21
Lorazepam	Lorazepam	130	29
Prednisone	Prednisone	128	76
Linzess	Linaclotide	127	17
Venlafaxine Hcl Er	Venlafaxine Hcl	125	15
Tradjenta	Linagliptin	122	13
Zolpidem Tartrate	Zolpidem Tartrate	122	22
Omeprazole	Omeprazole	118	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	110	56
Celecoxib	Celecoxib	107	24
Jardiance	Empagliflozin	105	suppressed
Ropinirole Hcl	Ropinirole Hcl	100	16
Ozempic	Semaglutide	95	15
Myrbetriq	Mirabegron	94	11
Tramadol Hcl	Tramadol Hcl	93	23
Simvastatin	Simvastatin	92	18
Cephalexin	Cephalexin	88	42
Lactulose	Lactulose	88	18
Labetalol Hcl	Labetalol Hcl	84	13
Aripiprazole	Aripiprazole	80	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	20
Bupropion Xl	Bupropion Hcl	78	14
Dexamethasone	Dexamethasone	78	44
Mounjaro	Tirzepatide	78	16
Pregabalin	Pregabalin	77	13
Allopurinol	Allopurinol	76	11
Tizanidine Hcl	Tizanidine Hcl	76	28
Fluticasone Propionate	Fluticasone Propionate	75	25
Metoclopramide Hcl	Metoclopramide Hcl	72	15
Valsartan	Valsartan	72	17
Dicyclomine Hcl	Dicyclomine Hcl	71	14
Megestrol Acetate	Megestrol Acetate	71	26
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	66	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	66	42
Xifaxan	Rifaximin	66	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	65	19
Bupropion Hcl Sr	Bupropion Hcl	58	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	58	14
Carbidopa-Levodopa	Carbidopa/Levodopa	57	suppressed
Benazepril Hcl	Benazepril Hcl	56	suppressed
Theophylline Er	Theophylline Anhydrous	56	suppressed
Baclofen	Baclofen	55	11
Citalopram Hbr	Citalopram Hydrobromide	55	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	54	suppressed
Meloxicam	Meloxicam	54	14
Fluconazole	Fluconazole	51	33
Benztropine Mesylate	Benztropine Mesylate	50	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	50	41
Humulin R	Insulin Regular, Human	50	13
Sucralfate	Sucralfate	50	15
Levofloxacin	Levofloxacin	49	33
Topiramate	Topiramate	48	suppressed
Diazepam	Diazepam	47	13
Latanoprost	Latanoprost	47	suppressed
Torsemide	Torsemide	47	suppressed
Budesonide	Budesonide	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	20
Symbicort	Budesonide/Formoterol Fumarate	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	suppressed
Ezetimibe	Ezetimibe	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Trulicity	Dulaglutide	44	suppressed
Novolin R	Insulin Regular, Human	42	12
Oxybutynin Chloride Er	Oxybutynin Chloride	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	41	11
Cefdinir	Cefdinir	41	32
Humalog	Insulin Lispro	41	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	41	13
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Rivastigmine	Rivastigmine	41	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	26
Xarelto	Rivaroxaban	40	suppressed
Spironolactone	Spironolactone	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Farxiga	Dapagliflozin Propanediol	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	12
Divalproex Sodium Er	Divalproex Sodium	37	suppressed
Lidocaine	Lidocaine	37	suppressed
Atenolol	Atenolol	36	suppressed
Irbesartan	Irbesartan	36	suppressed
Amoxicillin	Amoxicillin	35	19
Triamcinolone Acetonide	Triamcinolone Acetonide	34	18
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Methocarbamol	Methocarbamol	33	suppressed
Nystatin	Nystatin	33	21
Ertapenem	Ertapenem Sodium	32	22
Metformin Hcl Er	Metformin Hcl	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	23
Synthroid	Levothyroxine Sodium	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	12
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	27	suppressed
Digoxin	Digoxin	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Metronidazole	Metronidazole	27	11
Rybelsus	Semaglutide	27	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Invokana	Canagliflozin	26	suppressed
Oxcarbazepine	Oxcarbazepine	26	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Eszopiclone	Eszopiclone	25	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	25	suppressed
Primidone	Primidone	25	suppressed
Vraylar	Cariprazine Hcl	25	suppressed
Nystop	Nystatin	24	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	23	suppressed
Estradiol	Estradiol	23	suppressed
Leflunomide	Leflunomide	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Cholestyramine	Cholestyramine (With Sugar)	22	suppressed
Glycopyrrolate	Glycopyrrolate	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Prasugrel Hcl	Prasugrel Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Modafinil	Modafinil	19	suppressed
Ondansetron Odt	Ondansetron	19	15
Velphoro	Sucroferric Oxyhydroxide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Azelastine Hcl	Azelastine Hcl	18	suppressed
Azithromycin	Azithromycin	18	15
Colesevelam Hcl	Colesevelam Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Ingrezza	Valbenazine Tosylate	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Glipizide	Glipizide	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Acetazolamide	Acetazolamide	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Perphenazine	Perphenazine	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Humira	Adalimumab	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Unithroid	Levothyroxine Sodium	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Voriconazole	Voriconazole	12	suppressed
Xylocaine	Lidocaine Hcl	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	11	11
Metolazone	Metolazone	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$104.32 · 6 records	ABBVIE INC.	ACTIV.A.C., CAPLYTA, CONTRAVE, QULIPTA, REXULTI, UBRELVY	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error